Clinical Trial: Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07398560) titled 'Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study' on Jan. 25.

Brief Summary: This is a multicenter, single-arm, exploratory clinical study designed to observe and evaluate the efficacy and safety of adebrelimab combined with oral etoposide for elderly patients and patients with poor performance status in small cell lung cancer.

Study Start Date: Feb. 01

Study Type: INTERVENTIONAL

Condition: Small Cell Lung Cancer

Intervention: DRUG: Adebrelimab

Adebrelimab: 1200 mg, administered by intravenous infusion, once every 3...